Alpha-form or beta-form cyrstal of acetanilide derivative

Details for Australian Patent Application No. 2002344419 (hide)

Owner Astellas Pharma Inc.

Inventors Takasu, Toshiyuki; Maruyama, Tatsuya; Suzuki, Takayuki; Sakamoto, Kenichirou; Awamura, Yuji; Onda, Kenichi; Kawazoe, Souichirou

Agent Davies Collison Cave

Pub. Number AU-B-2002344419

PCT Number PCT/JP02/11217

PCT Pub. Number WO2003/037881

Priority 2001-332914 30.10.01 JP

Filing date 29 October 2002

Wipo publication date 12 May 2003

Acceptance publication date 13 December 2007

International Classifications

C07D 277/40 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 277/44 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 2001-332914 30.10.01 JP

10 July 2003 Application Open to Public Inspection

  Published as AU-B-2002344419

22 December 2005 Assignment before Grant

  Yamanouchi Pharmaceuticals Co., Ltd. The application has been assigned to Astellas Pharma Inc.

13 December 2007 Application Accepted

  Published as AU-B-2002344419

10 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002344420-PRODUCTION METHOD FOR SEMICONDUCTOR LIGHT EMITTING ELEMENT

2002344418-SKIN PREPARATION COMPRISING A TOCOPHEROL DERIVATIVE FOR EXTERNAL APPLICATION